MetLife, 5.875% Senior Notes due 11/21/2033 (MLG)

Total Debt

$21.35B

Quarterly · Period ending: · USD

MLG logo

MLG Total Debt

Latest reported$21.35B
MLG Quarterly Total Debt ($8.17B → $21.35B)
High-resolution chart · PNG

MLG total debt history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

MetLife, 5.875% Senior Notes due 11/21/2033 Total Debt — Quarterly (USD)
Period endingTotal Debt (USD)
21,345,000,000
21,130,000,000
20,183,000,000
19,832,000,000
19,906,000,000
19,229,000,000
18,715,000,000
18,845,000,000
18,362,000,000
19,261,000,000
18,828,000,000
18,796,000,000
17,899,000,000
17,949,000,000
17,980,000,000
17,861,000,000
17,030,000,000
17,327,000,000
17,430,000,000
17,511,000,000
18,065,000,000
17,964,000,000
18,149,000,000
18,042,000,000
17,967,000,000
17,959,000,000
16,851,000,000
16,734,000,000
16,653,000,000
16,287,000,000
16,244,000,000
16,844,000,000
18,161,000,000
19,378,000,000
19,307,000,000
20,046,000,000
22,912,000,000
19,940,000,000
19,852,000,000
19,922,000,000
19,857,000,000
21,183,000,000
21,317,000,000
20,049,000,000
20,063,000,000
21,007,000,000
19,579,000,000
19,682,000,000
20,076,000,000
20,086,000,000
22,021,000,000
21,545,000,000
21,870,000,000
22,014,000,000
22,387,000,000
27,109,000,000
22,172,000,000
26,682,000,000
27,570,000,000
33,693,000,000
36,860,000,000
36,664,000,000
36,380,000,000
29,760,000,000
30,014,000,000
28,983,000,000
22,620,000,000
23,821,000,000
25,685,000,000
24,853,000,000
16,084,000,000
20,808,000,000
21,388,000,000
14,758,000,000
13,842,000,000
18,296,000,000
17,753,000,000
17,493,000,000
14,358,000,000
14,551,000,000
15,124,000,000
13,426,000,000
13,436,000,000
12,929,000,000
13,417,000,000
8,534,000,000
8,857,000,000
8,261,000,000
9,444,000,000
8,775,000,000
9,345,000,000
8,638,000,000
9,005,000,000
7,922,000,000
5,586,000,000
4,306,000,000
3,488,000,000
3,980,000,000
3,983,000,000
3,053,000,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.